October 17th 2024
James Rider, PharmD, shared his experiences as a pharmacy manager at CVS.
October 15th 2024
Drug Topics sat down with Adam J. James, PharmD, to discuss learnings from his extensive experience at Rite Aid.
October 2nd 2023
September 20th 2023
Suicides among health care professionals are estimated to occur at a higher rate than in the general public.
August 13th 2023
What can pharmacists do to bring innovative care models into their stores to serve their communities?
Can warfarin improve psychotic symptoms?
A study suggests that warfarin use may lead to a decrease in and even long-term remission of psychotic symptoms in patients with schizophrenia.
Proposed new FDA rule might allow altered labeling of generic meds
FDA's proposed new rule would allow individual generic-drug application holders to update product labeling information to temporarily reflect changes in safety information prior to FDA review.
The ups and downs of generic drugs
Generics are still a good deal. But as they reach their maximum saturation point, the deal is changing.
Drug shortages continue; hospitals cope
Over the last few years, the number of drugs on shortage has remained the same. It may even have gone up. Hospitals continue to confront the issues and devise responses.
Will the pathway to approval of biosimilars run smoothly?
As of July 24, Sandoz became the first to file for approval of a biologic under the biosimilar pathway. What will happen next remains to be seen.
Global Pharmaceuticals: Innovative Products in Key Therapeutic Areas
Farewell to the druggist culture
When druggists morphed into pharmacists, an essential quality was lost. The need for speed has just about buried it. But you can bring it back.
Teva Generics
Teva Generics leads the U.S. generic pharmaceutical market in total and new prescriptions, with total prescriptions of approximately 523 million in 2013, representing one out of every seven generic prescriptions filled in the U.S.
Lupin Pharmaceuticals, Inc. committed to quality, innovation
Drug Topics Voices, August 2014
Feedback from pharmacists and other Drug Topics readers
Botanicals in diabetes treatment: A look at stevia
Medicinal plants and drugs of biological origin have their place in the treatment of chronic diseases. Among them, stevia shows promise as a possible source of new therapies for diabetes.
Corresponding responsibility: Implications for pharmacists and physicians
Physicians are responsible for prescribing and dispensing. Pharmacists have a corresponding responsibility to fill those prescriptions appropriately.
Opioids prescriptions: Are pharmacists waving white flags?
Pharmacists dealing with Rxs for controlled substances have their lists of red flags and greens flags. Are they now showing the white flag, as well?
Community pharmacy and CMS Star ratings
Available technology can help pharmacies improve patient adherence, boost patient outcomes, and earn high CMS Star measures. Everybody wins.
Smoking cessation and the pharmacist-patient relationship
Pharmacists are logical candidates to help patients quit smoking. Here are some of the reasons.
FDA unveils new drug pedigree requirements
Title II of the DQSA is the Drug Supply Chain Security Act. As of January 1, 2015, new changes and mandates will move all members of the supply chain closer to becoming mandatory oversight partners with FDA.
Collaboration in transitional care
New initiatives show that medication management is at the core of advanced discharge planning and transitional care. That's where pharmacists come in.
New products for pharmacists 08-10-2014
New Rx, generics, and OTC
Pharmacy products for the summer first-aid kit
Summer's not over yet. For customers planning August vacations or anyone with active children, here are some new options for the first-aid kit.
Paper Rxs are quickly becoming a thing of the past
Seven out of 10 prescribers use e-prescribing, and virtually all pharmacies are now equipped to receive them.
CVS pharmacy sales offset lost tobacco revenues
CVS Caremark reported a drop in front-store sales as a result of its decision to phase out tobacco products, but pharmacy sales drove second-quarter earnings past Wall Street expectations.
Walgreens installs time-delayed safes to deter robberies
Criminals will now have to stand around and wait for the safes to open. Wonder what they'll do while they're waiting.
Walgreens to remain headquartered in the U.S.
Walgreens told investors its intention to acquire its remaining 55% interest in European pharmacy giant Alliance Boots-and that the company will continue to be based in the United States.
Archaic North Dakota pharmacy ownership law targeted
Opponents of a North Dakota law that has kept retailers such as Wal-Mart and Walgreens from operating pharmacies in the state are hoping to overturn the law through a statewide ballot.
New vancomycin dosing tool
A young PharmD takes on a repetitive process and turns it into a mobile app.
Brief pharmacist intervention key to improved med adherence
When the Pennsylvania Project evaluated the impact on medication adherence of screenings and brief interventions by pharmacists, it found improvement in both adherence rates and cost savings.
Top stories from Drug Topics: July 2014
Here's what pharmacists were reading, talking, posting, and tweeting about throughout July 2014.
Harder-to-abuse oxycodone painkiller approved
FDA gives the nod to Purdue Pharma's Targiniq ER.
Health Mart introduces new marketing courses
At the recent McKesson ideaShare 2014 meeting in Orlando, Health Mart introduced four new courses designed to help its independent pharmacies market their services.